MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 10mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 10mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 10mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 5mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 5mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 5mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 5mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 5mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Chlordiazepoxide 5mg capsules (Kent Pharma (UK) Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Store in airtight containers, protect from light. Store in tight or well-closed containers.

Provenance

This compatibility recommendation is derived from Piriton 4mg tablets (GlaxoSmithKline Consumer Healthcare UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.